Skip to content

Construction and application of evidence-based prevention and management scheme of intrapartum fever

Construction and application of evidence-based prevention and management scheme of intrapartum fever

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063074
Enrollment
Unknown
Registered
2022-08-30
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prenatal fever

Interventions

Group 1 :
Group 2:

Sponsors

Guangzhou Women's and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Full-term pregnancy, single pregnancy, first place mother; 2. Normal listening, speaking, reading and writing skills; 3. Voluntary participation in research.

Exclusion criteria

Exclusion criteria: 1. Combined with serious medical and surgical diseases, such as diabetes, thyroid disease, etc.; 2. The first laboratory examination on admission shows that WBC > 10 x 10^9/L or C-reactive protein or procalcitonin > 0.1; 3. Symptoms of upper respiratory tract infection such as cold, fever, and runny nose before admission.

Design outcomes

Primary

MeasureTime frame
Prenatal fever rate;

Secondary

MeasureTime frame
Neonatal umbilical artery blood gas;Neonatal apger score;Lateral episiotomy rate;Vaginal midwifery rate;

Countries

China

Contacts

Public ContactLu Lijie

Guangzhou Women's and Children's Medical Center

371790319@qq.com+86 13560189265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026